Quoin Pharmaceuticals
QNRX
6 hedge funds and large institutions have $272K invested in Quoin Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
15% less capital invested
Capital invested by funds: $321K → $272K (-$49K)
25% less funds holding
Funds holding: 8 → 6 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$179K |
| 2 |
VF
Virtu Financial
New York
|
+$146K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$78.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$76.1K |
| 5 |
Jane Street
New York
|
+$57.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$256K |
| 2 |
Renaissance Technologies
New York
|
-$29K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7K |
| 4 |
Citigroup
New York
|
-$6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GSC
1
Ground Swell Capital
Folly Beach,
South Carolina
| $82K | +$179K | +87 | New |
|
|
VF
2
Virtu Financial
New York
| $67K | +$146K | +71 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $39K | +$78.2K | +38 | +950% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $34K | +$76.1K | +37 | New |
|
|
5
Jane Street
New York
| $26K | +$57.6K | +28 | New |
|
6
UBS Group
Zurich,
Switzerland
| $24K | +$47.3K | +23 | +1,150% |
|
|
7
Renaissance Technologies
New York
| – | -$29K | -12 | Closed |
|
|
8
Ameriprise
Minneapolis,
Minnesota
| – | -$256K | -4 | Closed |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| – | -$6K | -3 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$7K | -3 | Closed |
|
|
11
Citigroup
New York
| – | -$6K | -2 | Closed |
|
|
HF
12
HRT Financial
New York
| – | -$4K | -2 | Closed |
|
QNRX Hedge Fund Activity: Q3 2022 in Review
6 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2022, worth a combined $272K — down 15% from $321K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of QNRX and 4 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Ground Swell Capital, opening a new position worth an estimated $179K. The largest seller was Ameriprise, exiting entirely with an estimated $256K sold.
- 6 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q3 2022, down from 8 in Q2 2022.
- Funds reported $272K of Quoin Pharmaceuticals stock for Q3 2022, down 15% quarter-over-quarter.
- 4 funds opened new Quoin Pharmaceuticals positions in Q3 2022 and 6 closed out, a net change of -2 holders.
- The largest Quoin Pharmaceuticals buyer in Q3 2022 was Ground Swell Capital, an estimated $179K added.
- The largest Quoin Pharmaceuticals seller in Q3 2022 was Ameriprise, an estimated $256K sold.
Based on aggregated 13F filings for Q3 2022.